Ar­cutis wins la­bel ex­pan­sion for younger use of pso­ri­a­sis cream Zo­ryve

More than a year af­ter it was ap­proved for adults and chil­dren 12 years and old­er, Ar­cutis Bio­ther­a­peu­tics’ steroid-free top­i­cal cream for plaque pso­ri­a­sis is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER